NCT06974110 2026-04-15
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
Phase 1 Recruiting
MOMA Therapeutics
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
The University of Texas Health Science Center, Houston